Published by Josh White on 5th January 2021
(Sharecast News) - Speciality allergy-focussed pharmaceutical company Allergy Therapeutics announced on Tuesday that an ex-vivo biomarker study of blood samples from peanut allergy patients had started at Imperial College London.
URL: http://www.digitallook.com/dl/news/story/31550708/...